Kenneth Liu

Kenneth Liu has a strong background in formulation development, with extensive experience in the pharmaceutical industry. Kenneth is currently working as the Senior Director of Formulation Development at Kura Oncology, Inc. Prior to this role, they served as an Associate Director of Formulation Development at Bristol Myers Squibb. Kenneth also worked at MyoKardia as an Associate Director, where they achieved several key accomplishments including successfully developing suspension formulations and leading formulation development for NDA and MAA filings. Earlier in their career, they held various roles at Amneal Pharmaceuticals, where they contributed to the transfer and manufacture of clinical supplies and led the development of several FDA ANDA filings. Before that, Kenneth worked at Impax Laboratories, where they developed formulations and processes for multiple solid oral drugs and commercialized several products through scale-up and technical transfer. Overall, Kenneth Liu's work experience demonstrates their expertise in formulation development and their ability to successfully navigate complex projects in the pharmaceutical industry.

Kenneth Liu attended the University of California, Berkeley. However, no specific information regarding the start year, end year, degree name, or field of study is available.